Androgen Deprivation Therapy With or Without Radium-223 Dichloride in Patients With Newly Diagnosed Metastatic Prostate Cancer With Bone Metastases: Hoosier Cancer Research Network GU13-170
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Bicalutamide (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 22 Aug 2016 Status changed from not yet recruiting to recruiting.
- 14 Mar 2016 Planned End Date changed from 1 Dec 2019 to 1 Jan 2020 as reported by ClinicalTrials.gov.